Clinician's commentary: Atypical peritoneal cytology in ovarian and endometrial cancers

Peritoneal cytology results play an important role in staging, prognostication, and treatment recommendations in early-stage ovarian cancer. In endometrial cancer, while no longer part of staging criteria, peritoneal cytology results can influence patient-provider shared-decision making regarding adjuvant therapy choices after definitive surgery. We explore two cases demonstrating the impact uncertain cytology can have on patients and providers in these two gynecologic cancers.